Hyperprogression after immunotherapy in patients with malignant tumors of digestive system.
Zhi JiZhi PengJifang GongXiaotian ZhangJian LiMing LuZhihao LuLin ShenPublished in: BMC cancer (2019)
Hyperprogression was observed in a fraction of patients with malignant tumors of digestive system treated with ICIs. Further investigation is urgently needed.
Keyphrases